Aspis-cluster

From Laboratory Tool to Regulatory Acceptance

Why Promising Methods Stall Before They Reach Regulators

Every year, laboratories develop new assays, computational models, and testing strategies that outperform the tools currently used for safety assessment. Yet most of these methods never reach the desks of regulators, not because they fail scientifically, but because they fail the quieter test of trust. A method that works brilliantly in one laboratory may still be rejected if its results cannot be reproduced, explained, or defended in a regulatory context.

The gap between a laboratory tool and a regulatory accepted approach is therefore not a single leap but a long series of small, deliberate steps. Each step answers a question that regulators, industry scientists, and validation bodies will eventually ask. Understanding that journey is essential for anyone who wants their method to be adopted rather than admired.

The First Hurdle: Scientific Credibility

Before a method can be trusted by a regulator, it must first be trusted by the scientific community. This means the method must have a clear biological or mechanistic basis, a defined domain of applicability, and a transparent protocol that another laboratory can follow without private knowledge.

Credibility is built through activities such as:

  • Independent replication in multiple laboratories.
  • Publication in peer reviewed journals with full method details.
  • Open sharing of protocols, reference data, and known limitations.
  • Comparison against established reference methods.

Without this foundation, even the most elegant method remains a personal technique rather than a shared tool.

From Credibility to Formal Validation

Validation is where a method is tested against a defined set of performance criteria. This stage often follows frameworks such as those developed by international validation bodies, and it requires a level of documentation that laboratory researchers may find unfamiliar.

A typical validation pathway includes the following stages:

  1. Define the purpose and regulatory context of the method.
  2. Select reference chemicals with known outcomes.
  3. Run the method in multiple laboratories under blind conditions.
  4. Analyze reproducibility, sensitivity, and specificity.
  5. Publish the validation report for independent review.

Each stage produces evidence, and each piece of evidence reduces the uncertainty that regulators must manage when they consider accepting a new approach.

What Regulators Actually Need

Regulators are not looking for perfect methods. They are looking for methods whose performance and limitations are understood well enough that a decision can be defended. This is a subtle but important distinction.

Evidence TypeQuestion It Answers
Mechanistic basisWhy should this method work?
Reproducibility dataWill it work elsewhere?
Reference chemical resultsDoes it agree with known outcomes?
Defined limitationsWhen should it not be used?

A method that openly states its boundaries is often more acceptable than one that claims universal success. Regulators value honesty about uncertainty because it allows them to make proportionate decisions.

Trust is not claimed by a method; it is granted by the community that understands it.

Adoption Is a Shared Responsibility

Regulatory acceptance is not the final destination of a method but the beginning of its real use. Once accepted, a method must be maintained, updated, and supported by training materials and reference data. Developers, validation bodies, and regulators all play a role in keeping that trust alive.

For the ASPIS cluster and similar initiatives, the lesson is clear: turning a laboratory tool into a regulatory accepted approach requires scientific rigor, transparent validation, and continuous dialogue. The journey is long, but every step taken with openness brings safer and more ethical assessment closer to reality.

Latest articles